Key senators pivot on bipartisan insulin cost proposal; pharma's latest hires and departures

Taking stock of the drug industry, from the lab to the medicine chest

April 21, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Stefani Reynolds/The New York Times Key senators make a big pivot on bipartisan insulin cost proposal Sens. Jeanne Shaheen (D-N.H.) and Susan Collins (R-Maine) would extend the $35 cap on insured patients' costs to at least one insulin of each type and dose. By Rachel Cohrs STAT+ | HCA bags big first quarter as patient volumes soar HCA Healthcare beat Wall Street's expectations of profitability in the first quarter of 2023, as more people flocked to its facilities. By Bob Herman STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser